TrialEuropean journal of endocrinology2023

Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study.

Isabella Gashaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.